Antibiotic use in the emergency department. IV: Single-dose therapy and parenteral-loading dose therapy

Journal of Emergency Medicine

Volumn 14, Issue 5, 1996, Pages 619-628

  Hoang, Kim D ^a   Pollack Jr , Charles V ^a,b  

^a MARICOPA MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

bacteremia, treatment; bacterial pneumonia, treatment; cephalosporin antibiotics; fluconazole; macrolide antibiotics; metronidazole; penicillin antibiotics; pharyngotonsillitis, treatment; quinolone antibiotics; sexually transmitted diseases, treatment; sulfa antibiotics; urinary tract infection, treatment; vaginitis, treatment

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN; FLUCONAZOLE; MACROLIDE; METRONIDAZOLE; PENICILLIN G; QUINOLONE; SULFANILAMIDE;

ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL PNEUMONIA; DRUG USE; HUMAN; INFECTION; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; TONSILLITIS; TREATMENT PLANNING; URINARY TRACT INFECTION; VAGINITIS;

EID: 0030250525     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-4679(96)00141-2     Document Type: Article

References (130)

1. 1. Stolley PD, Backer MH, McEvilla JD, et al. Drug prescribing and use in an American community. Ann Intern Med. 1972; 76:537-40.
2. 2. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med. 1990;150:1881-4.
3. 3. Wandless I, Mucklow JC, Smith A, Prudham D. Compliance with prescribed medicines: a study of elderly patients in the community. J R Coll Gen Pract. 1979;29:391-6.
4. 4. Cockburn J, Reid AL, Bowman JA, Sanson-Fisher RW. Effects of intervention on antibiotic compliance in patients in general practice. Med J Aust. 1987;147:324-8.
5. 5. Cockburn J, Gibberd RW, Reid AL, Sanson-Fisher RW. Determinant of non-compliance with short term antibiotic regimens. BMJ. 1987;295:814-8.
6. 6. Marchant CD, Shurin PA. Therapy of otitis media. Pediatr Clin North Am. 1983;30:281-96.
7. 7. Lundgren K, Ingvarsson L. Antibiotic treatment of acute otitis media in children. In: Proceedings of the International Conference on Acute and Secretory Otitis Media, part I, Jerusalem, Israel, 17-22 November 1985, 1985:427-30.
8. 8. Kaleida PH, Casselbrant ML, Rockette HE, et al. Amoxicillin or myringotomy or both for acute otitis media: Results of a randomized clinical trial, Pediatrics. 1991;87:466-74.
9. 9. Ingvarsson L, Lundgren K. Penicillin treatment of acute otitis media in children. Acta Otolaryngol. 1982;94:283-7.
10. 10. Chaput de Saintonge DM, Levine DF, Savage IT, et al. Trial of three-day and ten-day courses of amoxicillin in otitis media. Br Med J. 1982;284:1078-81.
11. 11. Ploussard JH. Evaluation of five days of cefaclor vs ten days of amoxicillin therapy in acute otitis media. Curr Ther Res. 1984;36:641-5.
12. 12. Bain J, Murphy E, Ross F. Acute otitis media: clinical course among children who received a short course of high dose antibiotic. Br Med J. 1985;291:1243-6.
13. 13. Hendrickse WA, Kusmiesz H, Shelton S, Nelson JD. Five versus ten days of therapy for acute otitis media. Pediatr Infect Dis J. 1988;7:14-23.
14. 14. Charney E, Bynum R, Elredge D, et al. How well do patients take oral penicillin? A collaborative study in private practice. Pediatrics. 1967;40:188-95.
15. 15. Varsano I, Frydman M, Amir J, et al. Single intramuscular dose of ceftriaxone as compared to 7-day amoxicillin therapy for acute otitis media in children. Chemotherapy. 1988; 34(suppl 1):39-46.
16. 16. Green SM, Rothrock SG. Single-dose intramuscular ceftriaxone for acute otitis media in children. Pediatrics. 1993;91:23-30.
17. 17. Wannamaker LW, Rammelkemp CR Jr, Denny FW, et al. Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infection with various amounts of depot penicillin. Am J Med. 1951;10:673-95.
18. 18. Chamovitz R, Catanzaro FJ, Stetson CA, et al. Prevention of rheumatic fever by treatment of previous streptococcal infections: evaluation of benzathine penicillin G. N Engl J Med. 1951;251:466-71.
19. 19. Breese BB, Disney FA. The successful treatment of beta-hemolytic streptococcal infections in children with a single injection of repository penicillin (benzathine penicillin G). Pediatrics. 1955;15:516-21.
20. 20. Breese BB, Disney FA. A comparison of intramuscular and oral benzathine penicillin G in the treatment of streptococcal infections in children. J Pediatr. 1957;51:157-63.
21. 21. Breese BB, Disney FA. Penicillin in the treatment of streptococcal infections; a comparison of effectiveness of five different oral and one parenteral forms. N Engl J Med. 1957;259:57-62.
22. 22. Rheumatic Fever Committee of the Council on Rheumatic Fever and Congenital Heart Disease of the American Heart Association Statement. American Heart Association Circular, 1972.
23. 23. Bass JW, Crost FW, Knowles CR, et al. Streptococcal pharyngitis in children: A comparison of four treatment schedules with intramuscular penicillin G benzathine. JAMA. 1976; 235:1112-6.
24. 24. Bass JW. Long-acting penicillins: acceptability and tolerance. Pediatr Infect Dis. 1985;4:576-8.
25. 25. Committee on Rheumatic Fever and Infective Endocarditis of the American Heart Association. Prevention of rheumatic fever. Circulation. 1984;70:1118A-22A.
26. 26. Committee on Rheumatic Fever. A statement for health professionals by the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Circulation. 1988;78:1082-6.
27. 27. Arthur JD, Bass JW, York WB. How is suspected streptococcal pharyngitis managed? A study of what physicians actually think and do. Postgrad Med. 1984;75:241-8.
28. 28. Kline JA, Runge JW. Streptococcal pharyngitis: a review of pathophysiology, diagnosis, and management. J Emerg Med. 1994;12:665-80.
29. 29. Ronald AR, Silverman M, McCutchan JA, Corey L, Handsfield HH. Evaluation of new anti-infective drugs for the treatment of syphilis. Clin Inf Dis. 1992;15.
30. 30. Smith CA, Kamp M, Olansky S, Price EV. Benzathine penicillin G in the treatment of syphilis. Bull WHO. 1956;15:1087-96.
31. 31. Nicholas L. Treatment of early infectious syphilis with benzathine penicillin G. In: Proceedings of the World Forum on Syphilis and Other Treponematoses. 1962. Publication no. 997. Washington, DC: U.S. Department of Health, Education, and Welfare. 1964;296-301.
32. 32. Schroeter AL, Lucas JB, Price EV, Falcone VH. Treatment for early syphilis and reactivity of serologic tests. JAMA. 1972; 221:471-6.
33. 33. Fiumara NJ. Treatment of primary and secondary syphilis: serologic response. J Am Acad Dermatol. 1986;14:487-91.
34. 34. Moore MB. Epidemiologic treatment of contacts to infectious syphilis. In: Proceedings of the World Forum on Syphilis and Other Treponeraatoses. 1962. Publication no. 997. Washington, DC: U.S. Department of Health, Education and Welfare. 1964:340-2.
35. 35. Schroeter AL, Turner RH, Lucas JB, Brown WJ. Therapy for incubating syphilis: Effectiveness of gonorrhea treatment. JAMA. 1971;218:711-3.
36. 36. Hook EW III, Roddy RE, Handsfield HH. Ceftriaxone therapy for incubating and early syphilis. J Infect Dis. 1988;158:881-4.
37. 37. Handsfield HH, McCutchan JA, Corey L, Ronald AR. Evaluation of new anti-infective drugs for the treatment of uncomplicated gonorrhea in adults and adolescents. Clin Infect Dis. 1992;15(suppl 1):S123-30.
38. 38. Ashford WA, Golash RG, Hemming VG. Penicillinase-producing Neisseria gonorrhea. Lancet. 1976;2:657-8.
39. 39. Centers for Disease Control. 1993 sexually transmitted diseases treatment guidelines. MMWR. 1993;42:1-61.
40. 40. Christophersen J, Bollerup AC, From E, Ronne-Rasmussen JO, Quitzan K. Treating genitourinary and pharyngeal gonorrhoea with single dose ceftriaxone. Genitourin Med. 1989;65:14-7.
41. 41. Hansfield HH, McCormack WM, Hook EW III, et al. A comparison of single-dose cefixime with ceftriaxone as treatment for uncomplicated gonorrhea. N Engl J Med. 1991;325:1337-41.
42. 42. Goldstein AMB, Clark JH, Wickler MA. Comparison of single-dose ceftizoxime or ceftriaxone in the treatment of uncomplicated urethral gonorrhea. Sexual Trans Dis. 1991;18:180-2.
43. 43. Jones RB, Mogabgab WJ, McCormack WM, Wendel GD. Randomized comparison of cefotaxime and ceftriaxone in patients with uncomplicated gonorrhea. Clin Ther. 1991;13:550-6.
44. 44. Portilla I, Lutz B, Montalvo M, Mogabgab WJ. Oral cefixime versus intramuscular ceftriaxone in patients with uncomplicated gonococcal infections. Sexual Trans Dis. 1992;19:94-8.
45. 45. Plourde PJ, Tyndall M, Agoki E, et al. Single-dose cefixime versus single-dose ceftriaxone in the treatment of antimicrobial-resistant Neisseria gonorrhoea infection. J Infect Dis. 1992;166:919-22.
46. 46. Judson FN, Ehret JM, Handsfield HH. Comparative study of ceftriaxone and spectinomycin for treatment of pharyngeal and anorectal gonorrhea. JAMA. 1985;253:1417-9.
47. 47. Panikabutra K, Lee CT, Ho B, Bamberg P. Single dose oral norfloxacin or intramuscular spectinomycin to treat gonorrhea (PPNG and non-PPNG infections): analysis of efficacy and patient preference. Genitourin Med. 1988;64:235-40.
48. 48. Megran DW, Lefebvre K, Willetts V, Bowie WR. Single-dose oral cefixime versus amoxicillin plus probenecid for the treatment of uncomplicated gonorrhea in men. Antimicrob Agents Chemother. 1990;34:355-7.
49. 49. Asbach HW. Single dose oral administration of cefixime 400 mg in the treatment of acute uncomplicated cystitis and gonorrhea. Drugs. 1991;42(suppl 4):10-3.
50. 50. Dunnett DM, Moyer MA. Cefixime in the treatment of uncomplicated gonorrhea. Sexual Trans Dis. 1992;19(2):92-3.
51. 51. Echols RM, Heyd A, O'Keeffe BJ, Schacht P. Single-dose ciprofloxacin for the treatment of uncomplicated gonorrhea: a worldwide summary. Sex Trans Dis. 1994;21:345-53.
52. 52. Hook EW, Jones RB, Martin DH, et al. Comparison of ciprofloxacin and ceftriaxone as single-dose therapy for uncomplicated gonorrhea in women. Antimicrob Agents Chemother. 1993;37:1670-3.
53. 53. Cheong LL, Chan RK, Nadarajah M. Pefloxacin and ciprofloxacin in the treatment of uncomplicated gonococcal urethritis in males. Genitourin Med. 1992;68:260-2.
54. 54. Balachandran T, Roberts AP, Evans BA, Azadian BS. Single-dose therapy of anogenital and pharyngeal gonorrhea with ciprofloxacin. Int J STD AIDS. 1992;3:49-51.
55. 55. Lutz EB. Single-dose efficacy of ofloxacin in uncomplicated gonorrhea. Am J Med. 1989;87(suppl 6C):69S-74S.
56. 56. Black JR, Long JM, Zwickl BE, et al. Multicenter randomized study of single-dose ofloxacin versus amoxicillin-probenecid for treatment of uncomplicated gonococcal infection. Antimicrob Agents Chemother. 1989;33:167-70.
57. 57. Smith BL, Cummings MC, Covino JM, Benes S, Draft K, McConnack WM. Evaluation of ofloxacin in the treatment of uncomplicated gonorrhea. Sexual Trans Dis. 1991;18:18-20.
58. 58. Albrecht LM, Rybak MJ, Schubiner HH, Weiner LM. Single dose enoxacin for the treatment of uncomplicated urogenital gonorrhea. Sexual Trans Dis. 1989;16:114-7.
59. 59. Pabst KM, Siegel NA, Smith S, Black JR, Handsfield HH, Hook EW III. Multicenter, comparative study of enoxacin and ceftriaxone for treatment of uncomplicated gonorrhea. Sexual Trans Dis. 1989;16:148-51.
60. 60. Romanowski B, Hardy JS, Rafter MS, Draker J. Enoxacin in the therapy of anal and pharyngeal gonococcal infections. Sexual Trans Dis. 1989;16:190-1.
61. 61. Lassus A, Filho LA, Santos MFQ, Belli L. Comparison of fleroxacin and penicillin G plus probenecid in the treatment of acute uncomplicated gonococcal infections. Genitourin Med. 1992;68:317-20.
62. 62. Smith BL, Mogabgab WJ, Dalu ZA, et al. Multicenter trial of fleroxacin versus ceftriaxone in the treatment of uncomplicated gonorrhea. Am J Med. 1993;94(suppl 3A):81S-4S.
63. 63. Mogabgab WJ. Single-dose oral temafloxacin versus parenteral ceftriaxone in the treatment of gonococcal urethritis/cervicitis. Am J Med. 1991;91 (suppl 6A):145S-9S.
64. 64. Youssef RZ, Murray M, Holmes B, Mogabgab WJ. Cefotetan therapy for gonococcal urethritis and cervicitis. Sexual Trans Dis. 1990;17:99-101.
65. 65. Judson FN, Eron LJ, Lutz FB, Rand KH, Tennican PO, Mogabgab WJ. Multicenter study of a single 500 mg dose of cefotaxime for treatment of uncomplicated gonorrhea. Sexual Trans Dis. 1991;18:41-3.
66. 66. Haase DA, Nash RA, Nsanze H, et al. Single-dose ceftriaxone therapy of gonococcal ophthalmia neonatorum. Sexual Trans Dis. 1986;13:53-55.
67. 67. Haimovici R, Roussel TJ. Treatment of gonococcal conjunctivitis with single-dose intramuscular ceftriaxone. Am J Ophthalmol. 1989;107:511-4.
68. 68. Hooper DC, Wolfson JS. Fluoroquinolone antimicrobial agents. N Engl J Med. 1991;324:384-94.
69. 69. Toomey KE, Barnes RC. Treatment of Chlamydia trachomatis genital infection. Rev Infect Dis. 1991;12(suppl 6):S645-55.
70. 70. Martin DH, Mroczkowski TF, Dalu ZA, et al. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. N Engl J Med. 1992; 327:921-5.
71. 71. Fowler JE Jr, Stamey TA. Studies of introital colonization in women with recurrent urinary infections. The role of bacterial adherence. J Urol. 1977;117:472-6.
72. 72. Latham RH, Running K, Stamm WE. Urinary tract infections in young adult women caused by Staphylococcus saprophyticus. JAMA. 1983;250:3063-6.
73. 73. Tolkoff-Rubin NE, Rubin RH. Urinary tract infection: significance and management. Bull NY Acad Sci. 1986;62:129-48.
74. 74. Grunegerg RN, Brumfitt W. Single dose treatment of acute urinary tract infection: a controlled trial. Br Med J. 1967; 3:649-51.
75. 75. Slade N, Crowther ST. Multicentre survey of urinary tract infection in general practice: clinical trial of single dose treatment with sulfamethapyrazine. Br J Urol. 1972;44:105-9.
76. 76. Bailey RR, Abbott GD. Treatment of urinary tract infection with a single dose of trimethoprim-sulfamethoxazole. Can Med Assoc J. 1978;118:551-2.
77. 77. Bailey RR, Blake E. Treatment of uncomplicated urinary tract infection with a single dose of co-trimoxazole. NZ Med J. 1980;92:285-6.
78. 78. Bailey RR, Keenan TD, Eliott JC, Peddie BA, Bishop V. Treatment of bacterial cystitis with a single dose of trimethoprim, co-trimoxazole, or amoxicillin compared with a course of trimethoprim. NZ Med J. 1985;98:387-9.
79. 79. Harbord RB, Gruneberg RN. Treatment of urinary tract infection with a single dose of amoxicillin, co-trimoxazole, or trimethoprim. Br Med J. 1981;283:1301-2.
80. 80. Gossins G. Single-dose nitrofurantoin therapy for urinary tract infections in women. Curr Ther Res. 1984;35:925-31.
81. 81. Bailey RR, Abbott GD. Treatment of urinary tract infections with a single dose of amoxicillin. NZ Med J. 1976;84:324-5.
82. 82. Bailey RR, Abbott GD. Treatment of urinary tract infection with a single dose of amoxicillin. Nephron. 1977;18:316-20.
83. 83. Tolkoff-Rubin NE, Wilson ME, Zuromskis P, et al. Single-dose amoxicillin therapy of acute uncomplicated urinary tract infections in women. Antimicrob Agents Chemother. 1984; 25:626-9.
84. 84. Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med. 1993;329:1328-34.
85. 85. Pfau A, Sacks TG. Single dose quinolone treatment in acute uncomplicated urinary tract infection in women. J Urol. 1993; 149:532-4.
86. 86. Cox CE, Callery SV, Tack KJ. Clinical experience with ofloxacin in urinary tract infection. Infection. 1986;14(suppl 4):S303-4.
87. 87. Tanphaichitra D, Sahaphong S, Srimuang S. Ofloxacin, a new quinolone in the treatment of genitourinary and enteric infections. Infection. 1986;14(suppl 4):S321-3.
88. 88. Reeves DS, Lacey RW, Mummery RV, Mahendra M, Bint AJ, Newsom SWB. Treatment of acute urinary infection by norfloxacin or nalidixic acid/citrate: a multicentre comparative study. J Antimicrob Chemother. 1984;13(suppl B):99-105.
89. 89. Kirby CP. Treatment of simple urinary tract infections in general practice with a 3-day course of norfloxacin. J Antimicrob Chemother. 1984;13(suppl B):107-12.
90. 90. Saginur R, Nicolle LE. Single-dose compared with 3-day norfloxacin treatment of uncomplicated urinary tract infection in women. Arch Intern Med. 1992;152:1233-7.
91. 91. Iravani A. Multicenter study of single-dose and multiple-dose fleroxacin versus ciprofloxacin in the treatment of uncomplicated urinary tract infections. Am J Med. 1993;94(suppl 3A):S89-S96.
92. 92. Tolkoff-Rubin NE, Rubin RH. New approaches to the treatment of urinary tract infection. Am J Med. 1987;82(suppl 4A):270-7.
93. 93. Fleury FJ, van Bergen WS, Prentice RL, et al. Single dose of two grams of metronidazole for Trichomonas vaginalis infection. Am J Obstet Gynecol. 1977;128:320-2.
94. 94. Thin RN, Symonds MAE, Booker R, Cook S, Langlet F. Double-blind comparison of a single dose and a five-day course of metronidazole in the treatment of trichomoniasis. Br J Venereal Dis. 1979;55:354-6.
95. 95. Gabriel G, Robertson E, Thin RET. Single dose treatment of trichomoniasis. J Int Med Res. 1982;10:129-30.
96. 96. Lossick JG. Single-dose metronidazole treatment for vaginal trichomoniasis. Obstet Gynecol. 1980;56:508-10.
97. 97. Hager WD, Brown ST, Kraus SJ, Kleris GS, Perkins GJ, Henderson M. Metronidazole for vaginal trichomoniasis: Seven-day vs single-dose regimens. JAMA. 1980;244:1219-20.
98. 98. Aubert JM, Sesta HJ. Treatment of vaginal trichomoniasis: Single, 2-gram dose of metronidazole as compared with a seven-day course. J Reprod Med. 1982;27:743-5.
99. 99. Biswas MK. Bacterial vaginosis. Clin Obstet Gynecol. 1993; 36:166-76.
100. 100. Lugo-Miro VI, Green M, Mazur L. Comparison of different metronidazole therapeutic regimens for bacterial vaginosis: a meta-analysis. JAMA. 1992;268:92-5.
101. 101. Schlicht JR. Treatment of bacterial vaginosis. Ann Pharmacother. 1994;28:483-7.
102. 102. Sweet RL. New approaches for the treatment of bacterial vaginosis. Am J Obstet Gynecol. 1993;169:479-82.
103. 103. Anon. Oral fluconazole for vaginal candidiasis. Med Lett. 1994; 36:81-2.
104. 104. van Heusden AM, Merkus HMWM, Euser R, Verhoeff A. A randomized, comparative study of a single dose of fluconazole versus a single topical dose of clotrimazole in the treatment of vaginal candidosis among general practitioners and gynaecologists. Eur J Obstet Gynecol Reprod Biol. 1994;55:123-7.
105. 105. Anderson GM, Barrat J, Bergan T, Brammer KW, Cohen J, Dellenbach P. A comparison of single-dose oral fluconazole with 3-day intravaginal clotrimazole in the treatment of vaginal candidiasis. Br J Obstet Gynecol. 1989;96:226-32.
106. 106. Sobel JD, Brooker D, Stein GE, et al. Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis. Am J Obstet Gynecol. 1995;172:1263-8.
107. 107. Woolley PD, Higgins SP. Comparison of clotrimazole, fluconazole and itraconazole in vaginal candidiasis. BJCP. 1995; 49:65-6.
108. 108. Bennish ML, Salam MA, Khan WA, Khan AM. Treatment of shigellosis: III. Comparison of one-or two-dose ciprofloxacin with standard 5-day therapy. A randomized, blinded trial. Ann Intern Med. 1992;117:727-34.
109. 109. Peter G, Smith AL. Group A streptococcal infections of the skin and pharynx. N Engl J Med. 1977;297:311-17.
110. 110. Gerber SA. Streptococcal infections: group A - hemolytic streptococci. In: Rudolph AM, ed. Rudolph's pediatrics, 19th ed. Norwalk, CT: Appleton & Lange, 1991:614-8.
111. 111. Cunha BA. Therapy review: treatment of pelvic inflammatory disease. Clin Pharmacol. 1990;9:275-85.
112. 112. Peterson HB, Galaid EI, Zenilman JM. Pelvic inflammatory disease: review of treatment options. Rev Inf Dis. 1990; 12(suppl 6):S656-64.
113. 113. Mercer LJ, Block BS, Hajj SN. Measurement of C-reactive protein to compare ceftizoxime versus cefoxitin/doxycycline therapy for septic pelvis: a preliminary report. Clin Ther. 1987; 10(suppl A):59-65.
114. 114. Wolner-Hanssen P, Paavonen J, Kiviat N, et al. Outpatient treatment of pelvic inflammatory disease with cefoxitin and doxycycline. Obstet Gynecol. 1988;71:595-600.
115. 115. Peterson HB, Walker CK, Kahn JG, Washington AE, Eschenbach DA, Faro S. Pelvic inflammatory disease: key treatment issues and options. JAMA. 1991;266:2605-11.
116. 116. Douglas J, Judson F, Spenser N, et al. Multiple strain outbreak of penicillinase-producing Neisseria gonorrhoea: Denver, Colorado, 1986. JAMA. 1987;258:1713-4.
117. 117. Judson FN. Management of antibiotic-resistant Neisseria gonorrhoea. Ann Intern Med. 1989;110:5-7.
118. 118. Le Saux N, Ronald AR. Role of ceftriaxone in sexually transmitted disease. Rev Infect Dis. 1989;11:299-309.
119. 119. Angel JL, O'Brien WF, Finan MA, Morales WJ, Lake M, Knuppel RA. Acute pyelonephritis in pregnancy: a prospective study of oral versus intravenous antibiotic therapy. Obstet Gynecol. 1990;76:28-32.
120. 120. Karachalios GN. Randomized comparative study of amoxicillin-clavulanic acid and co-trimoxazole in the treatment of acute urinary tract infections in adults. Antimicrob Agents Chemother. 1985;28:693-4.
121. 121. Stamm WE, McKevitt M, Counts GW. Acute renal infection in women: treatment with trimethoprim-sulfamethoxazole or ampicillin for two or six weeks: a randomized trial. Ann Intern Med. 1987;106:341-5.
122. 122. Sandberg T, Englund G, Lincoln K, Nilsson LG. Randomized double-blind study of norfloxacin and cefadroxil in the treatment of acute pyelonephritis. Eur J Clin Microbiol Infect Dis. 1990;9:317-23.
123. 123. Ward G, Jorden RC, Severance HW. Treatment of pyelonephritis in an observation unit. Ann Emerg Med. 1991;20:256-61.
124. 124. Dagan R, Powell KR, Hall CB, Menegus MA. Identification of infants unlikely to have serious bacterial infection although hospitalized for suspected sepsis. J Pediatr. 1985;107:855-60.
125. 125. McCarthy CA, Powell KR, Jaskiewicz JA, et al. Outpatient management of selected infants younger than two months of age evaluated for possible sepsis. Pediatr Infect Dis J. 1990; 9:385-9.
126. 126. Baskin MN, Fleisher GR, O'Rourke EJ. Outpatient management of febrile infants 28-89 days of age with intramuscular administration of ceftriaxone. J Pediatr. 1992;120:22-7.
127. 127. Teele DW, Pelton SI, Grant MJ, Herskowitz J, Rosen DJ, Allen CE. Bacteremia in febrile children under 2 years of age: results of cultures of blood of 600 consecutive febrile children seen in a "walk-in" clinic. J Pediatr. 1975;87:227-30.
128. 128. Bass JW, Steele RW, Whittler RR, Weiss ME, Bell V, Weisser AH. Antimicrobial treatment of occult bacteremia: a multicenter cooperative study. Pediatr Infect Dis J. 1993;12:466-73.
129. 129. Baraff LJ, Lee SI. Fever without source: management of children 3 to 36 months of age. Pediatr Infect Dis J. 1992;11:146 51.
130. 130. Baraff LJ, Bass JW, Fleisher GR, et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Pediatrics. 1993;92:1-12.